Expression of suppressors of cytokine signaling during liver regeneration
Open accessAbstract
The cytokines TNF and IL-6 play a critical role early in liver regeneration following partial hepatectomy (PH). Since IL-6 activates signal transducers and activators of transcription (STATs), we examined whether the suppressors of cytokine signaling (SOCS) may be involved in terminating IL-6 signaling. We show here that SOCS-3 mRNA is induced 40-fold 2 hours after surgery. SOCS-2 and CIS mRNA are only weakly induced, and SOCS-1 is not detectable. SOCS-3 induction after PH is transient and correlates with a decrease in STAT-3 DNA binding and a loss of tyrosine 705 phosphorylation. This response is markedly reduced in IL-6 knockout (KO) mice. TNF injection induces SOCS-3 mRNA in wild-type mice (albeit weakly compared with the increase observed after PH) but not in TNF receptor 1 or IL-6 KO mice. In contrast, IL-6 injection induces SOCS-3 in these animals, demonstrating a requirement for IL-6 in SOCS-3 induction. IL-6 injection into wild-type mice also induces SOCS-1, -2, and CIS mRNA, in addition to SOCS-3. Together, these results suggest that SOCS-3 may be a key component in downregulating STAT-3 signaling after PH and that SOCS-3 mRNA levels in the regenerating liver are regulated by IL-6.
AI snapshot
Written from the paper’s full text.
TL;DR
After partial hepatectomy, SOCS-3 mRNA and protein are induced transiently in mouse liver, correlating with STAT-3 activation and inactivation. IL-6 is a major regulator of this SOCS-3 induction, while TNF alone induces a weaker, different SOCS profile.
Key findings
- PH induces SOCS-3 mRNA 40- to 50-fold at 2 hours, sustained for 4 hours, declining by 8 hours and returning to baseline by 24 hours; SOCS-3 protein is detected from 2 hours through 8–10 hours. SOCS-2 and CIS are only weakly induced (four- to tenfold, sometimes undetectable), and SOCS-1 is not induced.
- STAT-3 tyrosine 705 phosphorylation and DNA binding are transient after PH: phosphorylation is first detected at 2 hours and decreases to background by 8 hours; robust DNA binding appears at 2 hours and disappears between 3 and 6 hours. Sham-operated mice show weaker STAT-3 DNA binding.
- In IL-6 KO mice after PH, SOCS-3 mRNA induction is severely reduced and SOCS-3 protein is not detected; STAT-3 tyrosine phosphorylation is weaker and DNA binding is impaired. Densitometry showed approximately a threefold induction of SOCS-3 at 2 hours in WT versus IL-6 KO liver.
- TNF injection induces SOCS-3 in WT mice (<15-fold) but not in TNF-R1 or IL-6 KO mice; IL-6 injection induces SOCS-3 40- to 60-fold in all three strains and also induces SOCS-1, -2, and CIS, unlike PH.
Methods
- Male C57BL/6 WT, IL-6 KO, and TNF-R1 KO mice underwent two-thirds partial hepatectomy or sham laparotomy; some mice received intraperitoneal mTNF (25 µg/kg) or hIL-6 (1 mg/kg), with saline controls.
- Liver tissue was analyzed by Northern blot for SOCS-1, -2, -3, and CIS mRNA normalized to cyclophilin, by EMSA for STAT DNA binding and supershift, and by immunoprecipitation/immunoblot for STAT-3 phosphorylation and SOCS-3 protein.
- Data were analyzed by one-way ANOVA followed by Newman-Keuls test; cell culture controls included IL-6-stimulated AML12, HepG2, and RAW 264.7 cells.
Limitations
- The paper states that more precise analysis of SOCS-3’s role awaits SOCS-3-transgenic or knockout mice, and that such systems require conditional expression because constitutive expression or ablation causes embryonic death.
- The paper reports that Western blot detection of CIS, SOCS-1, and SOCS-2 proteins was unsuccessful because commercially available antibodies could not detect these proteins in liver lysates.
- Evident from the text: the main findings are correlative timing and loss-of-function cytokine/receptor models rather than direct SOCS-3 perturbation; the authors also note that a single IL-6 injection does not faithfully reproduce PH signaling and that other cytokines may contribute to SOCS-3 induction after PH.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
9 of 40 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured
- Premisecitation
IL-6 participates in hepatocyte proliferation in vivo not only in PH but in injury-induced models of liver proliferation.
“These studies and others suggest that IL-6 participates in hepatocyte proliferation in vivo not only in PH but in injury-induced models of liver proliferation (12).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] Streetz, 2000, Gut source
- Findingown data
No STAT-1 homodimer activity was seen in these experiments.
“No STAT-1 homodimer activity was seen in these experiments.”
Quote in the paperNot a substantial claim - Findingown data
Sham-operated mice have a detectable, but much weaker STAT-3 DNA-binding activity.
“Sham-operated mice have a detectable, but much weaker STAT-3 DNA-binding activity (Figure 1b).”
Quote in the paperNot a substantial claim - Findingown data
STAT-3 is the major STAT family member activated after PH.
“Use of STAT-1 and STAT-5 oligonucleotide probes demonstrates that STAT-3 is the major STAT family member activated after PH (Figure 1c).”
Quote in the paperSubstantial claim - Findingown data
Tyrosine 705 phosphorylation of STAT-3 correlates with its ability to bind DNA.
“Importantly, tyrosine 705 phosphorylation of STAT-3 correlates with its ability to bind DNA (Figure 1b).”
Quote in the paperSubstantial claim
- Findingown data
After PH, SOCS-3 mRNA is much more sustained, being detected between 2 and 8 hours after PH.
“After PH, SOCS-3 mRNA is much more sustained because mRNA is detected between 2 and 8 hours after PH.”
Quote in the paperSubstantial claim - Findingown data
After PH, SOCS-3 induction is approximately sixfold greater than CIS.
“In contrast, after PH, SOCS-3 induction is approximately sixfold greater than CIS.”
Quote in the paperNot a substantial claim - Findingown data
CIS and SOCS-2 mRNA was detectable after PH, albeit much weaker than SOCS-3.
“While SOCS-1 mRNA was not induced by PH, CIS and SOCS-2 mRNA was detectable, albeit much weaker than SOCS-3 (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
A weak induction of SOCS-3 is detectable in sham-operated mice.
“A weak induction of SOC-3 is detectable in sham-operated mice (Figure 2).”
Quote in the paperNot a substantial claim - Findingown data
TNF injection into WT mice induces SOCS-3 in a time-dependent manner compared with control and saline injection.
“Figure 5 shows that TNF injection into WT mice induces SOCS-3 in a time-dependent manner compared with control and saline injection.”
Quote in the paperSubstantial claim - Findingcitation
Only STAT-3 homodimers are seen after PH.
“Only STAT-3 homodimers are seen after PH (Figure 2c and ref. 16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Cressman, 1995, Hepatology source
- Findingown data
Compared with SOCS-3, which is induced 40- to 60-fold after PH, CIS and SOCS-2 are only weakly induced after PH.
“Compared with SOCS-3, which is induced 40-to 60-fold after PH, CIS and SOCS-2 were only weakly induced.”
Quote in the paperSubstantial claim - Findingown data
Sham-operated mice also have a detectable, but much weaker STAT-3 tyrosine 705 phosphorylation and DNA-binding capacity.
“Sham-operated mice also have a detectable, but much weaker STAT-3 tyrosine 705 phosphorylation and DNAbinding capacity (Figure 4a and Figure 1b).”
Quote in the paperNot a substantial claim - Findingown data
By 8 hours after PH, STAT-3 is no longer tyrosine phosphorylated.
“SOCS-3 has not been shown to have catalytic phosphatase activity, yet by 8 hours after PH, STAT-3 is no longer tyrosine phosphorylated (Figure 1a).”
Quote in the paperSubstantial claim - Findingown data
IL-6 injection induces SOCS-3 mRNA in all three genetic strains examined (WT, TNF-R1 KO, and IL-6 KO mice).
“Figure 6 shows that IL-6 injection induces SOCS-3 mRNA in all three genetic strains, indicating that IL-6 can bypass the defects in TNF-R1-and IL-6 KO mice.”
Quote in the paperSubstantial claim - Findingown data
PH induces SOCS-3 to much higher levels (>40-fold) than TNF injection (<15-fold).
“It is important to note that PH induces SOCS-3 to much higher levels (>40-fold) than TNF injection (<15-fold) (compare Figure 5b to Figure 2b).”
Quote in the paperSubstantial claim - Findingown data
In IL-6 KO mice, STAT-3 tyrosine phosphorylation was detectable by 2 hours after surgery, although it was weaker than the levels seen in WT animals.
“In IL-6 KO mice, STAT-3 tyrosine phosphorylation was detectable by 2 hours after surgery, although it was weaker than the levels seen in WT animals (Figure 4a, top).”
Quote in the paperSubstantial claim - Findingcitation
In addition to SOCS-3, injection of IL-6 induces CIS, SOCS-1, and SOCS-2 mRNA in the liver.
“In addition to SOCS-3, injection of IL-6 induces CIS, SOCS-1, and SOCS-2 mRNA (Figure 6) in the liver, an observation reported by other laboratories (20).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Starr, 1997, Nature source
- Findingown data
Detection of SOCS-3 protein is consistent with the induction of SOCS-3 mRNA.
“Detection of SOCS-3 protein is consistent with the induction of SOCS-3 mRNA (Figure 2a).”
Quote in the paperSubstantial claim - Findingown data
In IL-6 KO mice, SOCS-3 mRNA induction after PH is severely reduced compared with WT tissue.
“Although SOCS-3 message levels were induced compared with either control or sham-operated mice, SOCS-3 mRNA induction in the IL-6 KO liver was severely reduced after PH compared with WT tissue (Figure 3, a and b).”
Quote in the paperSubstantial claim - Findingown data
SOCS-1 mRNA was not induced by PH.
“While SOCS-1 mRNA was not induced by PH, CIS and SOCS-2 mRNA was detectable, albeit much weaker than SOCS-3 (data not shown).”
Quote in the paperSubstantial claim - Findingown data
SOCS-3 transcripts and protein are induced during the priming phase of liver regeneration.
“The studies presented here show that SOCS-3 transcripts and protein are induced during the priming phase of liver regeneration and that this induction is greatly diminished in IL-6 KO mice.”
Quote in the paperSubstantial claim - Findingown data
The magnitude of SOCS-3 induction after IL-6 injection is comparable to that seen after partial hepatectomy (PH).
“The magnitude of SOCS-3 induction after IL-6 injection is now comparable with that seen after PH.”
Quote in the paperNot a substantial claim - Findingcitation
In the human hepatoma cell line HepG2, SIF A, B (STAT-3:STAT-1), and C (STAT-1:STAT-1) DNA complexes are all detected after IL-6 treatment.
“One notable exception is the human hepatoma cell line, HepG2 (Figure 1c), where SIF A, B (STAT-3:STAT-1), and C (STAT-1:STAT-1) DNA complexes are all detected after IL-6 treatment (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Bode, 1999, FEBS Lett source
- Findingreasoning
SOCS-3 induction is not completely abolished in IL-6 KO mice after PH.
“The SOCS-3 induction is not completely abolished in IL-6 KO mice after PH, perhaps uncovering the actions of other cytokines.”
Quote in the paperSubstantial claim - Findingown data
SOCS-3 induction during liver regeneration is greatly diminished in IL-6 KO mice.
“The studies presented here show that SOCS-3 transcripts and protein are induced during the priming phase of liver regeneration and that this induction is greatly diminished in IL-6 KO mice.”
Quote in the paperSubstantial claim - Findingown data
SOCS-1 and -2 mRNA levels are detectable after TNF injection.
“Moreover, SOCS-1 and -2 mRNA levels are detectable after TNF injection.”
Quote in the paperNot a substantial claim - Findingown data
CIS, SOCS-1, and SOCS-2 are not strongly induced after PH.
“In contrast, CIS, SOCS-1, and SOCS-2 are not strongly induced after PH.”
Quote in the paperSubstantial claim - Findingown data
SOCS-3 mRNA is rapidly induced in the mouse liver after PH compared with sham-operated animals.
“SOCS-3 mRNA is rapidly induced in the mouse liver after PH compared with sham-operated animals (Figure 2, a and b).”
Quote in the paperSubstantial claim - Findingown data
At 2 hours after PH there was approximately a threefold induction of SOCS-3 in livers of WT mice compared with IL-6 KO mice.
“Densitometry analysis showed that at 2 hours after PH there was approximately a threefold induction of SOC-3 in livers of WT mice compared with IL-6 KO mice (data not shown).”
Quote in the paperSubstantial claim - Findingown data
The magnitude of induction and spectrum of SOCS molecules that are induced is markedly different after TNF injection when compared with that seen after PH.
“Additionally, we find that the magnitude of induction and spectrum of SOCS molecules that are induced is markedly different after TNF injection when compared with that seen after PH.”
Quote in the paperSubstantial claim - Findingown data
STAT-3 DNA-binding activity is greatly impaired after PH in IL-6 KO mice liver.
“Similar to Cressman et al. ( 9), our results show that STAT-3 DNA-binding activity is greatly impaired after PH in IL-6 KO mice liver.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Cressman, 1996, Science source
- Findingown data
After TNF injection, SOCS-3 induction is about twofold greater than CIS induction.
“After TNF injection, we see that SOCS-3 induction is about twofold greater than CIS induction.”
Quote in the paperNot a substantial claim - Findingown data
The ability of STAT-3 to bind DNA was impaired in IL-6 KO mice after PH.
“However, the ability of STAT-3 to bind DNA was impaired (Figure 4b).”
Quote in the paperSubstantial claim - Findingown data
IL-6 injection induces SOCS-3 mRNA levels 40- to 60-fold in mouse liver.
“IL-6 injection induces SOCS-3 message levels 40-to 60-fold (Figure 6, a and b).”
Quote in the paperSubstantial claim - Findingown data
TNF did not induce SOCS-3 in the liver of either TNF-R1 KO or IL-6 KO mice.
“When TNF-R1 KO or IL-6 KO mice were injected with TNF, we found that TNF did not induce SOCS-3 in the liver of either mouse strain (Figure 5b).”
Quote in the paperSubstantial claim - Findingown data
None of the other SOCS messages were detectable in IL-6 KO liver after PH.
“None of the other SOCS messages were detectable (data not shown).”
Quote in the paperNot a substantial claim - Findingnone given
The timing of SOCS-3 expression correlates very well with the inactivation of STAT-3 DNA binding after PH.
“While SOCS-3 is induced after PH and the timing of its expression correlates very well with the inactivation of STAT-3 DNA binding, more precise analysis of the role of SOCS-3 awaits the establishment of SOCS-3-transgenic or KO mice.”
Quote in the paperSubstantial claim - Premisecitation
In mice lacking either TNF receptor 1 (p55/TNF-R1) or IL-6, hepatocyte proliferation and liver mass restoration are significantly impaired after PH.
“Moreover, in mice lacking either TNF receptor 1 (p55/TNF-R1) or IL-6, hepatocyte proliferation and liver mass restoration are significantly impaired after PH (8,9).”
Quote in the paperSubstantial claim0 of 2 sources checked - Study design and conductown data
The STAT-3 DNA-binding activity being measured is due to a STAT-3 homodimer, not a STAT-1:STAT-3 heterodimer.
“Supershift analysis con-firms that the STAT-3 DNA-binding activity being measured is due to a STAT-3 homodimer, not a STAT-1:STAT-3 heterodimer (Figure 1d).”
Quote in the paperNot a substantial claim - Premisecitation
Two known regulators of the priming phase of liver regeneration are the cytokines TNF and IL-6.
“Two known regulators of the priming phase of liver regeneration are the cytokines TNF and IL-6 (7)(8)(9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites (7)(8)(9)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Two mechanisms, SOCS-3 and a tyrosine phosphatase, may coexist to ensure complete inhibition of cytokine signals mediated by STATs.
“Thus two mechanisms, SOCS-3 and a tyrosine phosphatase, may coexist to ensure complete inhibition of cytokine signals mediated by STATs.”
Quote in the paperSubstantial claim- Rests on an assumption: STAT-3 induces SOCS-3 mRNA, leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.
- Study design and conductown data
Western blot detection of CIS, SOCS-1, and SOCS-2 proteins was unsuccessful because commercially available antibodies were unable to detect these proteins in liver lysates.
“Western blot analysis detection of CIS, SOCS-1, and SOCS-2 proteins was unsuccessful as the commercially available Ab's (Santa Cruz Biotechnologies Inc. and Zymed Inc., Camarillo, California, USA) were unable to detect these proteins in liver lysates (data not shown).”
Quote in the paperNot a substantial claim - Interpretationreasoning
SOCS-3 appears to be the major isoform regulating cytokine signaling during liver regeneration.
“SOCS-3 appears to be the major isoform regulating cytokine signaling during liver regeneration.”
Quote in the paperSubstantial claim- Rests on an assumption: STAT-3 induces SOCS-3 mRNA, leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.
- Interpretationreasoning
Inhibition of STAT-3 signaling may ensure the termination of the priming phase of liver regeneration.
“Inhibition of STAT-3 signaling may ensure the termination of the priming phase of liver regeneration.”
Quote in the paperSubstantial claim- Rests on an assumption: STAT-3 induces SOCS-3 mRNA, leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.
- Interpretationown data
Induction of CIS after TNF injection seems to require only TNF-R1 and not IL-6.
“In contrast, induction of CIS after TNF injection seems to require only TNF-R1 and not IL-6.”
Quote in the paperSubstantial claim - Interpretationown data
The induction of SOCS-3 after PH is, for the most part, dependent on IL-6.
“Since SOCS-3 induction is severely blunted in IL-6 KO liver after PH, the induction of SOCS-3 after PH is, for the most part, dependent on IL-6.”
Quote in the paperSubstantial claim - Interpretationreasoning
A single injection of IL-6 does not faithfully reproduce the signaling parameters of PH.
“Moreover, the lack of induction of the other SOCS isoforms after PH suggests that a single injection of IL-6 does not faithfully reproduce the signaling parameters of PH.”
Quote in the paperSubstantial claim - Interpretationown data
TNF is not the sole mediator of SOCS-3 induction after PH.
“These data suggest that TNF is not the sole mediator of SOCS-3 induction after PH.”
Quote in the paperSubstantial claim - Premisecitation
Priming and progression of hepatocyte proliferation after PH requires the actions of TNF and IL-6 and growth factors such as TGF-alpha and HGF.
“Priming and progression of hepatocyte proliferation after PH requires the actions of TNF and IL-6 and growth factors such as TGF-α and HGF (1,3,5,27).”
Quote in the paperSubstantial claim0 of 4 sources checked - Interpretationreasoning
Besides IL-6, other factors, cytokines, or growth factors must directly or indirectly influence SOCS-3 induction after PH.
“Besides IL-6, there must be other factors, cytokines, or growth factors, that directly or indirectly influence SOCS-3 induction after PH.”
Quote in the paperSubstantial claim - Interpretationown data
IL-6 is a major regulator of SOCS-3 induction after PH.
“These results suggest that IL-6 is a major regulator of SOCS-3 induction after PH.”
Quote in the paperSubstantial claim - Interpretationreasoning
In liver regeneration, SOCS-3 participates in a negative-feedback loop turning off IL-6-mediated STAT-3 activation.
“Thus in liver regeneration, SOCS-3 participates in a negative-feedback loop turning off IL-6-mediated STAT-3 activation.”
Quote in the paperSubstantial claim- Rests on an assumption: STAT-3 induces SOCS-3 mRNA, leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.
- Interpretationreasoning
Oncostatin M (OSM), leukemia inhibitory factor (LIF), and cardiotrophin-1 (CT-1) could be the cytokines that cooperate with IL-6 during liver regeneration.
“Oncostatin M (OSM), leukemia inhibitory factor (LIF), and cardiotrophin-1 (CT-1), members of the IL-6 cytokine family that can induce STAT-3 DNA binding, could be the cytokines that cooperate with IL-6 during regeneration.”
Quote in the paperSubstantial claim - Interpretationreasoning
SOCS-3 appears to play an important role in inhibiting the IL-6-signaling pathway.
“SOCS-3 appears to play an important role in inhibiting the IL-6-signaling pathway.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 13
- May combine two claims. 33
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the liver, IL-6 activates multiple signaling pathways that culminate in the induction of genes involved in growth, hepatocyte-specific metabolic functions, and the acute-phase response.
“In the liver, IL-6 activates multiple signaling pathways that culminate in the induction of genes involved in growth, hepatocyte-specific metabolic functions, and the acute-phase response (13).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [13] Heinrich, 1990, Biochem J source
The section on IL-6-responsive elements in acute-phase protein genes reports IL-6-induced gene transcription, and the Actions section describes increased acute-phase protein synthesis in human hepatocytes. But the Signal transduction section says the underlying mechanisms were still unknown; the cited passages do not establish multiple signaling pathways or induction of genes for hepatocyte growth and specific metabolic functions. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWhen IL-6 binds to its receptor complex composed of IL-6R and a gp130 homodimer, a cascade of signaling events is initiated, most notably the Jak/STAT pathway.
“When IL-6 binds to its receptor complex composed of a specific receptor subunit, the IL-6 receptor (IL-6R), and a gp130 homo dimer, a cascade of signaling events is initiated, most notably the Jak/STAT pathway (14,15).”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe levels of TNF and IL-6 increase after PH, with the peak of TNF circulating levels preceding the peak levels of IL-6.
“The levels of these cytokines increase after PH, with the peak of TNF circulating levels preceding the peak levels of IL-6 (8,10,11).”
Quote in the paperNot a substantial claim1 of 3 sources checkedMay combine two claims.
PremisecitationOSM, LIF, and CT-1 have been implicated in liver functions such as development, hepatocyte differentiation, or inflammation, but have not yet been examined in liver regeneration.
“These cytokines have been implicated in liver functions such as development, hepatocyte differentiation, or inflammation (31)(32)(33), but have yet to be examined in liver regeneration.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [31] Miyajima, 2000, Cytokine Growth Factor Rev source
- cites [32] Peters, 1995, FEBS Lett source
The Introduction and Results and discussion link CT-1, LIF, and OSM to hepatocyte acute-phase responses associated with inflammation. The paper does not address liver development or hepatocyte differentiation, and although it does not study liver regeneration, it does not establish that these cytokines had yet to be examined in that setting. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [33] Omori, 1996, Lab Invest
May combine two claims.
PremisecitationNascent SOCS-3 blocks the activation of STAT-3 by binding to the receptor complex via gp130 at tyrosine 759 and/or by binding and inhibiting Jak2 activity.
“In the first mechanism, nascent SOCS-3 blocks the activation of STAT-3 by binding to the receptor complex via gp130 at tyrosine 759 (34,35) and/or by binding and inhibiting Jak2 activity (36).”
Quote in the paperNot a substantial claim2 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPossible tyrosine phosphatases include an unidentified nuclear tyrosine phosphatase activity that inactivates IFN-gamma-stimulated STAT-1 and the SH2-containing phosphatases SHP-1 and SHP-2, which regulate cytokine signals in other tissues.
“Possible tyrosine phosphatases include an unidentified nuclear tyrosine phosphatase activity that has been reported to inactivate IFN-γ-stimulated STAT-1 (37) and the SH2-containing phosphatases, SHP-1 and SHP-2, which regulate cytokine signals in other tissues (38).”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationConstitutive expression or ablation of SOCS-3 results in embryonic death.
“These expression systems require conditional expression of SOCS-3 within the parenchymal cells of the liver since constitutive expression or ablation results in embryonic death (40).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [40] Marine, 1999, Cell source
May combine two claims.
FindingcitationRobust STAT-3 DNA-binding activity is detected by 2 hours and rapidly disappears between 3 to 6 hours after PH.
“As has been demonstrated previously (8, 9, 16), robust STAT-3 DNA-binding activity is detected by 2 hours and rapidly disappears between 3 to 6 hours.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Findingown dataSTAT-3 tyrosine 705 phosphorylation is first detected by 2 hours after PH and decreases to background levels by 8 hours.
“STAT-3 tyrosine 705 phosphorylation is first detected by 2 hours after surgery and decreases to background levels by 8 hours (Figure 1a, top).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPhosphorylation of serine 727 of STAT-3 can be weakly detected, but the signal is variable.
“Phosphorylation of serine 727 of STAT-3 can be weakly detected (Figure 1a, middle), but the signal is variable.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIncreased SOCS-3 protein levels were first detected by 2 hours with sustained expression until 8 and 10 hours after PH.
“Increased SOCS-3 protein levels were first detected by 2 hours with sustained expression until 8 and 10 hours (Figure 2c, top).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenBoth STAT-3 activity and SOCS-3 protein are no longer detectable by 8 hours after PH.
“Both STAT-3 activity and SOCS-3 protein are no longer detectable by 8 hours after PH.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe low level of tyrosine 705 phosphorylation of STAT-3 in the KO mice after PH correlates with weak STAT-3 DNA binding and weak induction of SOCS-3.
“The low level of tyrosine 705 phosphorylation of STAT-3 in the KO mice after PH correlates with weak STAT-3 DNA binding (Figure 4b) and weak induction of SOCS-3 (Figure 3a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTNF injection also transiently induces CIS mRNA and SOCS-2 and SOCS-1 mRNAs.
“TNF injection also transiently induces CIS mRNA (Figure 5b) and SOCS-2 and SOCS-1 mRNAs (data no shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIL-6 injection also induces SOCS-1, SOCS-2, and CIS mRNA expression, a pattern not seen after PH.
“However, IL-6 injection also induces SOCS-1, -2, and CIS mRNA expression, a pattern not seen after PH.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSOCS-3 message is first detected at 1 hour and disappears rapidly after TNF injection.
“SOCS-3 message is first detected at 1 hour and disappears rapidly (Figure 5a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCIS is induced in the liver of IL-6 KO mice but not in TNF-R1 KO mice after TNF injection.
“In contrast to SOCS-3, CIS is induced in the liver of IL-6 KO mice but not in TNF-R1 KO mice.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSOCS-3 mRNA is induced by 1 hour and rapidly declines by 2 hours after IL-6 injection.
“SOCS-3 mRNA is induced by 1 hour and rapidly declines by 2 hours after IL-6 injection (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSOCS-3 protein is detectable after IL-6 injection but not after TNF injection.
“SOCS-3 protein can be detected after IL-6 injection, but not after TNF injection (Figure 6c).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSOCS-3 protein was detected in WT by immunoblot analysis, but not in IL-6 KO liver.
“Moreover, SOCS-3 protein was detected in WT by immunoblot analysis, but not in IL-6 KO liver (Figure 3c).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationBoth hepatocytes in vivo and in culture respond to IL-6 treatment in a similar manner, with only STAT-3 homodimers (SIF A) found.
“Moreover, both hepatocytes in vivo and in culture respond to IL-6 treatment in a similar manner; that is, only STAT-3 homodimers (SIF A) are found (unpublished observations and ref. 30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Bode, 1999, FEBS Lett source
May combine two claims.
Findingown dataPH induced CIS and SOCS-2 levels only between fourfold and tenfold compared with controls, and in some experiments no induction was detected.
“PH induced CIS and SOCS-2 levels only between fourfold and tenfold compared with controls, and in some experiments no induction was detected.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA 40-to 50-fold increase of SOCS-3 mRNA is seen at 2 hours and is sustained for 4 hours when the levels start declining at 8 hours after PH and return to baseline levels by 24 hours.
“A 40-to 50-fold increase of SOCS-3 mRNA is seen at 2 hours and is sustained for 4 hours when the levels start declining at 8 hours after PH and return to baseline levels by 24 hours (Figure 2b).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral mechanisms are known to be involved in inactivating STAT pathways: SHP-1 and -2, PIAS, and SOCS.
“To date, there are several mechanisms known to be involved in inactivating STAT pathways: the SH2-containing protein tyrosine phosphatases, SHP-1 and -2, the protein inhibitors of activated STATs (PIAS), and the suppressors of cytokine signaling (SOCS) (reviewed in refs.4,[17][18][19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites reviewed in refs.4,[17][18][19]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDepending on the tissue or cell type, the mRNA is short lived and the half-life of the SOCS protein is between 1 to 2 hours.
“Depending on the tissue or cell type, the mRNA is short lived and the half-life of the SOCS protein is between 1 to 2 hours (23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Siewert, 1999, Eur J Biochem source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationSTAT-3 is activated after PH as the result of increased IL-6 levels, implicating both IL-6 and STAT-3 as part of the priming mechanism for hepatocyte proliferation.
“It has been demonstrated previously that STAT-3 is activated after PH as the result of increased IL-6 levels (8, 9, 16), implicating both IL-6 and STAT-3 as part of the priming mechanism for hepatocyte proliferation.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataSTAT-3 tyrosine 705 phosphorylation and DNA-binding activity are transiently activated after surgery.
“Thus, STAT-3 tyrosine 705 phosphorylation and DNA-binding activity are transiently activated after surgery.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPreoperative injection of IL-6 rescues the defects in hepatocyte proliferation and returns a number of early signal transduction pathways to levels seen in wild-type mice.
“Preoperative injection of IL-6 not only rescues the defects in hepatocyte proliferation, but returns a number of early signal transduction pathways to levels seen in wild-type (WT) mice (9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Cressman, 1996, Science source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFor regeneration to take place, normally quiescent hepatocytes must gain proliferative capacity and undergo a transition from G0 to G1, a process known as priming.
“For regeneration to take place, normally quiescent hepatocytes must gain proliferative capacity and undergo a transition from G0 to G1, a process known as priming (1,6).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Study design and conductown dataSpecific STAT-3 binding was confirmed by supershift analysis with a specific STAT-3 Ab, and competition with a 200-fold excess of unlabeled probe confirmed that only STAT-3 bound to the SIE probe.
“Specific STAT-3 binding was analyzed by supershift analysis with a specific STAT-3 Ab, and competition with a 200-fold excess of unlabeled probe confirmed that only STAT-3 bound to the SIE probe (Figure 4b).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPH appears to selectively upregulate SOCS-3 and not other members of the SOCS family.
“Thus, PH appears to selectively upregulate SOCS-3 and not other members of the SOCS family.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe induction of SOCS-3 correlates with the activation and inactivation of STAT-3, suggesting that in liver regeneration SOCS-3 participates in a negative-feedback loop to decrease STAT-3 activity.
“Importantly, the induction of SOCS-3 correlates with the activation and inactivation of STAT-3, suggesting that in liver regeneration SOCS-3 participates in a negative-feedback loop to decrease STAT-3 activity.”
Quote in the paperSubstantial claim- Rests on an assumption: The STAT family of transcription factors mediates the induction of SOCS genes.
- Rests on an assumption: SOCS proteins participate in a feedback loop to inhibit STAT activity as well as cytokine signals.
May combine two claims.
Interpretationown dataSOCS-3 is the major SOCS family member induced after PH, and the induction of SOCS-3 mRNA and protein levels is transient.
“Taken together, these results indicate that SOCS-3 is the major SOCS family member induced after PH, and the induction of SOCS-3 mRNA and protein levels is transient.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataIL-6 injection bypasses the lack of TNF and IL-6 signaling and induces all SOCS molecules examined in murine liver.
“In summary, IL-6 injection bypasses the lack of TNF and IL-6 signaling and induces all SOCS molecules examined in murine liver.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenSOCS mRNA levels were normalized to cyclophilin levels at each time point.
“SOCS mRNA levels were normalized to cyclophilin levels at each time point.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe blots were stripped and reprobed with β-actin to ensure equal loading.
“The blots were stripped and reprobed with β-actin to ensure equal loading (Figure 2c, bottom).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataSOCS-3 induction is dependent on IL-6 and, perhaps, TNF-signaling pathways.
“These results suggest that SOCS-3 induction is dependent on IL-6 and, perhaps, TNF-signaling pathways.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenSham operation was performed as laparotomy, otherwise sham-operated mice were treated the same as PH mice.
“Laparotomy was performed as the sham operation, otherwise the sham-operated mice were treated the same as PH mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataWhile TNF can induce SOCS-3, this induction is much weaker and more transient compared with the induction following PH.
“These results suggest that while TNF can induce SOCS-3, this induction is much weaker and more transient compared with the induction following PH.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationOther mechanisms such as PIAS may also play a role in inhibiting early cytokine signaling during PH.
“Other mechanisms such as PIAS (39) that downregulate cytokine signaling in other cells may also play a role in inhibiting early cytokine signaling during PH.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Shuai, 2000, Oncogene source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningExisting, activated (tyrosine-phosphorylated) pools of STAT-3 may be inactivated by dephosphorylation through the actions of a tyrosine phosphatase.
“Secondly, existing, activated pools of STAT-3 (i.e., tyrosine phosphorylated) may be inactivated by dephosphorylation through the actions of a tyrosine phosphatase.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe priming phase of hepatocyte replication probably ends at 5-6 hours after PH, perhaps even earlier.
“The priming phase of hepatocyte replication probably ends at 5-6 hours after PH, perhaps even earlier.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The STAT family of transcription factors mediates the induction of SOCS genes.
“Importantly, the STAT family of transcription factors mediates the induction of SOCS genes.”
The paper relies on this without support.
SOCS proteins participate in a feedback loop to inhibit STAT activity as well as cytokine signals.
“Thus, SOCS proteins participate in a feedback loop to inhibit STAT activity as well as cytokine signals.”
The paper relies on this without support.
The mechanisms that downregulate or turn off the cytokine signaling pathways during liver regeneration are unclear.
“However, the mechanisms that downregulate or”
The paper relies on this without support.
TNF levels increase after PH, activating NF-kappaB, which upregulates IL-6 mRNA, resulting in elevated serum levels of IL-6.
“TNF levels increase after PH, activating the transcription factor, NF-κB, which in turn upregulates IL-6 mRNA, resulting in elevated serum levels of IL-6.”
The paper relies on this without support.
IL-6 stimulates hepatic STAT-3 by inducing phosphorylation at tyrosine 705, which allows nuclear translocation and DNA binding.
“IL-6 stimulates hepatic STAT-3 by inducing phosphorylation at tyrosine 705, which allows nuclear translocation and DNA binding.”
The paper relies on this without support.
STAT-3 induces SOCS-3 mRNA, leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.
“STAT-3 also induces SOCS-3 mRNA leading to an increase in SOCS-3 protein levels, which downregulate IL-6-stimulated STAT-3.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
SOCS-3 protein is both present and absent at 8 hours
MinorThe results describe sustained SOCS-3 protein expression through 8 and 10 hours after PH, whereas the discussion says it is no longer detectable by 8 hours.
“Increased SOCS-3 protein levels were first detected by 2 hours with sustained expression until 8 and 10 hours (Figure 2c, top).”
“Both STAT-3 activity and SOCS-3 protein are no longer detectable by 8 hours after PH.”
Figure 5 caption contradicts CIS induction in IL-6 KO mice
MinorThe caption says TNF induces neither SOCS-3 nor CIS in IL-6 KO liver, but the results state that CIS is induced in those mice.
“TNF injection induces SOCS-3 and CIS mRNA in a time-dependent manner in WT, but not in TNF-R1 KO and IL-6 KO mouse liver.”
“In contrast to SOCS-3, CIS is induced in the liver of IL-6 KO mice but not in TNF-R1 KO mice.”
STAT-3 serine phosphorylation site differs between methods and results
MinorThe methods identify an antibody against STAT-3 phosphoserine 729, but the results identify the measured signal as phosphorylation of serine 727.
“anti-phosphotyrosine 705 and anti-phosphoserine 729 STAT-3 Ab's (9131 and 9134, respectively)”
“Phosphorylation of serine 727 of STAT-3 can be weakly detected (Figure 1a, middle), but the signal is variable.”
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828 · see citing works
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734 · see citing works
Self-citationInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · see citing works
Self-citationA family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066 · see citing works
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408 · see citing works
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,287 · see citing works
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,187 · see citing works
Fausto, N. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80412-2 · Cited by 1,022 · see citing works
Self-citationYamada, Y., Kirillova, I., Peschon, J. J., & Fausto, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1441 · Cited by 944 · see citing works
Self-citationdel Olmo, J. A., Peña, A., Serra, M. Á., Wassel, A., Benages, A., & Rodrigo, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(01)68827-5 · Cited by 895 · see citing works
Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration.
Fausto, N., Laird, A., & Webber, E. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529831 · Cited by 620 · see citing works
Self-citationImada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610 · see citing works
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596 · see citing works
SOCS: physiological suppressors of cytokine signaling
Krebs, D. L., & Hilton, D. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2813 · Cited by 463 · see citing works
Nicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J.-G., Silva, A., Asimakis, M., Farley, A., Nash, A. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100135197 · Cited by 456 · see citing works
Nicholson, S. E., Willson, T. A., Farley, A., Starr, R., Zhang, J., Baca, M., Alexander, W. S., Metcalf, D., Hilton, D. J., & Nicola, N. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.375 · Cited by 407 · see citing works
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., & Diehl, A. M. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.263.4.g579 · Cited by 401 · see citing works
Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., & Schaper, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12848 · Cited by 388 · see citing works
Self-citationModulation of STAT signaling by STAT-interacting proteins
Shuai, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203522 · Cited by 379 · see citing works
Capacitative calcium entry channels
Putney, J. W., & McKay, R. R. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199901)21:1 · Cited by 373 · see citing works
SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis
Marine, J.-C., McKay, C., Wang, D., Topham, D. J., Parganas, E., Nakajima, H., Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura, A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80049-5 · Cited by 372 · see citing works
Rapid activation of the stat3 transcription complex in liver regeneration
Cressman, D. E., Diamond, R. H., & Taub, R. (1995) · Hepatology · doi:10.1002/hep.1840210531 · Cited by 314 · see citing works
Shp-2 Tyrosine Phosphatase: Signaling One Cell or Many
Feng, G.-S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4668 · Cited by 285 · see citing works
Yamada, Y., Webber, E. M., Kirillova, I., Peschon, J. J., & Fausto, N. (1998) · Hepatology · doi:10.1002/hep.510280410 · Cited by 260 · see citing works
Self-citationSTAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition
Fukada, T., Ohtani, T., Yoshida, Y., Shirogane, T., Nishida, K., Nakajima, K., Hibi, M., & Hirano, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6670 · Cited by 247 · see citing works
Interleukin 6 and liver regeneration
STREETZ, K. L., LUEDDE, T., MANNS, M. P., & TRAUTWEIN, C. (2000) · Gut · doi:10.1136/gut.47.2.309 · Cited by 238 · see citing works
A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1
Haspel, R. L., & Darnell, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10188 · Cited by 203 · see citing works
LPS and TNFα induce SOCS3 mRNA and inhibit IL‐6‐induced activation of STAT3 in macrophages
Bode, J. G., Nimmesgern, A., Schmitz, J., Schaper, F., Schmitt, M., Frisch, W., Häussinger, D., Heinrich, P. C., & Graeve, L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01662-2 · Cited by 196 · see citing works
Self-citationSteer, C. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.14.7589980 · Cited by 163 · see citing works
Role of Oncostatin M in hematopoiesis and liver development
Miyajima, A., Kinoshita, T., Tanaka, M., Kamiya, A., Mukouyama, Y., & Hara, T. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00003-4 · Cited by 153 · see citing works
Taub, R., Greenbaum, L., & Peng, Y. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007104 · Cited by 139 · see citing works
Trautwein, C., Rakemann, T., Niehof, M., Rose-John, S., & Manns, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964411 · Cited by 131 · see citing works
Different protein turnover of interleukin‐6‐type cytokine signalling components
Siewert, E., Müller‐Esterl, W., Starr, R., Heinrich, P. C., & Schaper, F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00719.x · Cited by 121 · see citing works
Self-citationPierce, R. H., Campbell, J. S., Stephenson, A. B., Franklin, C. C., Chaisson, M. L., Poot, M., Kavanagh, T. J., Rabinovitch, P. S., & Fausto, N. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64533-6 · Cited by 119 · see citing works
Self-citationNutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review
Holeček, M. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00158-6 · Cited by 79 · see citing works
(1996) · PubMed · Cited by 75 · see citing works
Signal transduction during liver regeneration
BRENNER, D. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.1998.13.s1.93 · Cited by 72 · see citing works
Cytokine signaling: Inhibitors keep cytokines in check
Kovanen, P. E., & Leonard, W. J. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80079-2 · Cited by 49 · see citing works
A new hepatocyte stimulating factor: cardiotrophin‐1 (CT‐1)
Peters, M., Roeb, E., Pennica, D., zum Büschenfelde, K.-H. M., & Rose-John, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00972-c · Cited by 39 · see citing works
Rapid activation of the Stat3 transcription complex in liver regeneration
Cressman, D. E. (1995) · Hepatology · doi:10.1016/0270-9139(95)90068-3 · Cited by 24 · see citing works
Tumour necrosis factor alpha--mediator of apoptosis and cell proliferation of hepatocytes.
Plümpe, J., Streetz, K. L., Manns, M. P., et al. (1999) · PubMed · Cited by 6 · see citing works
Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor
Yamada, Y., Webber, E. M., Kirillova, I., Peschon, J. J., & Fausto, N. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199901000-00011 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Plumpe, 1999, Ital J Gastroenterol Hepatol, 31, 235
- Akerman, 1992, Am J Physiol, 263, G579
- Omori, 1996, Lab Invest, 75, 15
Cited by
Sorted by citations
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378 · see citing works
Self-citationLiver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567 · see citing works
“pl?O14543">SOCS3 , which correlates with the subsequent downregulation of phosphorylated STAT3, thereby terminating the IL-6 signa”
BackgroundSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904 · see citing works
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · see citing works
“Interestingly, recent evidence suggests that some of the observed effects of TNF- may be mediated by its ability to induce IL-6 and IL-6 receptor expression in tissues such as the liver and muscle (38,39).”
BackgroundSOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840 · see citing works
Scar–free healing: from embryonic mechanisms to adult therapeutic intervention
Ferguson, M. W. J., & O'Kane, S. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2004.1475 · Cited by 812 · see citing works
“The initial priming signal for liver regeneration is the simultaneous effects of interleukin 6 and TNF alpha (Yamada et al. 1997; Fausto 2000; Campbell et al. 2001 ).”
BackgroundSenn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620 · see citing works
Foundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamışlıgil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 514 · see citing works
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · see citing works
Emanuelli, B., Peraldi, P., Filloux, C., Carine Chavey, A., Freidinger, K., Hilton, D. J., Hotamışlıgil, G. S., & OBBERGHEN, E. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104602200 · Cited by 449 · see citing works
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333 · see citing works
Self-citationSubramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 281 · see citing works
“For example, SOCS-3 is up-regulated 40-fold 2 h after partial hepatectomy in mice [178].”
BackgroundOpposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15841 · Cited by 291 · see citing works
“In this model, SOCS3 but not SOCS1 is markedly induced, which correlates with activation of STAT3 but absent STAT1 activation (52).”
Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
Wang, H., Lafdil, F., Kong, X., & Gao, B. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.536 · Cited by 268 · see citing works
“Rapid activation of STAT3 has been well-documented during liver regeneration after PHx or liver injury [59,84-86].”
BackgroundNew concepts in liver regeneration
Riehle, K. J., Dan, Y. Y., Campbell, J. S., & Fausto, N. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06539.x · Cited by 245 · see citing works
Self-citationMao, S. A., Glorioso, J. M., & Nyberg, S. L. (2014) · Translational research · doi:10.1016/j.trsl.2014.01.005 · Cited by 245 · see citing works
“SOCS3 prevents phosphorylation of STAT3, leading to its downregulation.(67) This results in a blockade of the IL-6 signal.”
BackgroundStem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly
Alison, M. R., Islam, S., & Lim, S. G. (2008) · The Journal of Pathology · doi:10.1002/path.2453 · Cited by 211 · see citing works
“Numerous growth factors and cytokines have been implicated in the initiation and control of this regenerative response [1,10–16], with the activation of seemingly critical transcription factors, such as AP-1, NFκB and STAT-3.”
BackgroundCritical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease
Houlihan, D. D., & Newsome, P. N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.040 · Cited by 189 · see citing works
Liver Regeneration: Analysis of the Main Relevant Signaling Molecules
Tao, Y.-C., Wang, M.-L., Chen, E., & Tang, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/4256352 · Cited by 191 · see citing works
“STAT3 is able to upregulate the expression of suppressors of cytokine signaling (SOCS), an important negative regulator of cytokine signaling, leading to the downregulation of gp130 signals [10, 11].”
BackgroundEstablishment, Characterization, and Long–Term Maintenance of Cultures of Human Fetal Hepatocytes
Lázaro, C. A., Croager, E. J., Mitchell, C., Campbell, J. S., Yu, C., Foraker, J. E., Rhim, J. A., Yeoh, G. C., & Fausto, N. (2003) · Hepatology · doi:10.1053/jhep.2003.50448 · Cited by 187 · see citing works
Self-citationInterleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration
Wüestefeld, T., Klein, C., Streetz, K. L., Betz, U. A. K., Lauber, J., Buer, J., Manns, M. P., Müller, W., & Trautwein, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208470200 · Cited by 176 · see citing works
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
Jin, X., Zimmers, T. A., Perez, E. A., Pierce, R. H., Zhang, Z., & Koniaris, L. G. (2006) · Hepatology · doi:10.1002/hep.21087 · Cited by 173 · see citing works
Chaisson, M. L., Brooling, J. T., Ladiges, W., Tsai, S. Y., & Fausto, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15295 · Cited by 181 · see citing works
“Separation and transfer of RNA was performed as previously described (23).”
MethodSelf-citationRegulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
Riehle, K. J., Campbell, J. S., McMahan, R. S., Johnson, M. M., Beyer, R. P., Bammler, T. K., & Fausto, N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070820 · Cited by 161 · see citing works
Self-citationHost factors and failure of interferon-α treatment in hepatitis C virus
Gao, B., Hong, F., & Radaeva, S. (2004) · Hepatology · doi:10.1002/hep.20139 · Cited by 159 · see citing works
Rigby, R. J., Simmons, J. G., Greenhalgh, C. J., Alexander, W. S., & Lund, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210286 · Cited by 153 · see citing works
“IL-6 potently induces SOCS3 in macrophages, T cells and hepatocytes and SOCS3 limits IL-6-mediated STAT3 activation and induction of acute-phase response genes in these cell types (Campbell et al., 2001; Croker et al., 2003; Chen et al., 2006).”
BackgroundMavragani, C. P., Niewold, T. B., Moutsopoulos, N. M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23062 · Cited by 155 · see citing works
“A STAT-3 inhibitor, suppressor of cytokine signaling 3 (SOCS-3), is inducible by TNFα and may contribute to reduced production of PDCs (30).”
BackgroundMechanisms of liver regeneration and their clinical implications
Fausto, N., & Riehle, K. J. (2005) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-005-0979-y · Cited by 136 · see citing works
Self-citationCytokines are systemic effectors of lymphatic function in acute inflammation
Aldrich, M. B., & Sevick-Muraca, E. M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.015 · Cited by 125 · see citing works
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Brand, S., Dambacher, J., Beigel, F., Zitzmann, K., Heeg, M. H. J., Weiß, T. S., Prüfer, T., Olszak, T., Steib, C. J., Storr, M., et al. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00239.2006 · Cited by 122 · see citing works
“It has been demonstrated that SOCS-3 transcripts and protein are induced during the priming phase of liver regeneration and that this induction is greatly diminished in IL-6 knockout mice (12).”
BackgroundTeoh, N., Leclercq, I. A., Peňa, A. D., & Farrell, G. C. (2003) · Hepatology · doi:10.1053/jhep.2003.50009 · Cited by 121 · see citing works
SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases
Fujimoto, M., & Naka, T. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/470468 · Cited by 120 · see citing works
“SOCS genes are induced through MyD88 during liver regeneration [26, 27].”
BackgroundThe role of cytokines in liver failure and regeneration: potential new molecular therapies
Galun, E., & Axelrod, J. H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00326-9 · Cited by 114 · see citing works
Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury
Leclercq, I. A., Field, J., & Farrell, G. C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00270-1 · Cited by 107 · see citing works
Nerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106 · see citing works
Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
Lou, T., Zhang, Z., Xi, Z., Liu, K., Li, L., Liu, B., & Huang, F. (2010) · Inflammation · doi:10.1007/s10753-010-9276-2 · Cited by 105 · see citing works
“Recent evidence showed that some of the observed effects of TNF-α may be mediated by its ability to induce IL-6 and IL-6 receptor expression in tissues such as the liver and muscle [36, 37].”
BackgroundYeoh, G. C., Ernst, M., Rose‐John, S., Akhurst, B., Payne, C. J., Long, S., Alexander, W. S., Croker, B. A., Grail, D., & Matthews, V. B. (2007) · Hepatology · doi:10.1002/hep.21535 · Cited by 102 · see citing works
Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice
Huang, H. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i45.6605 · Cited by 101 · see citing works
Campbell, J. S., Riehle, K. J., Brooling, J. T., Bauer, R. L., Mitchell, C., & Fausto, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2522 · Cited by 99 · see citing works
“Fifty micrograms of total protein was subjected to SDS-PAGE and transferred to polyvinylidene difluoride membranes as described (13).”
BackgroundMethodInfluentialSelf-citationInterleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3
Denson, L. A., Held, M. A., Menon, R. K., Frank, S. J., Parlow, A. F., & Arnold, D. L. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00178.2002 · Cited by 97 · see citing works
“Importantly, in these studies, intact TNF signaling was not required for IL-6 to elicit maximal initial induction of Socs-1, -2, and -3 RNA and SOCS-3 protein (6).”
BackgroundInfluentialEffect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model
Marubashi, S., Sakon, M., Nagano, H., Gotoh, K., Hashimoto, K., Kubota, M., Kobayashi, S., Yamamoto, S., Miyamoto, A., Dono, K., et al. (2004) · Surgery · doi:10.1016/j.surg.2004.03.012 · Cited by 89 · see citing works
Regulators of hepcidin expression
Roth, M., Meynard, D., & Coppin, H. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.005 · Cited by 84 · see citing works
The quest for liver progenitor cells: A practical point of view
Dollé, L., Best, J., Mei, J., Battah, F. A., Reynaert, H., van Grunsven, L. A., & Geerts, A. E. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.009 · Cited by 83 · see citing works
“A plethora of cytokines, growth factors and enzymes fulfil this well-orchestrated regeneration [23,44,154].”
Shu, J., Kren, B. T., Xia, Z., Wong, P. Y.-P., Li, L., Hanse, E. A., Min, M. X., Li, B., Albrecht, J. H., Zeng, Y., et al. (2011) · Hepatology · doi:10.1002/hep.24421 · Cited by 79 · see citing works
da Silva, C. G., Studer, P., Skroch, M., Mahiou, J., Minussi, D. C., Peterson, C. R., Wilson, S. W., Patel, V. I., Ma, A., Csizmadia, E., et al. (2013) · Hepatology · doi:10.1002/hep.26197 · Cited by 77 · see citing works
“IL-6 signaling in hepatocytes is finely regulated by a negative feedback loop provided by IL-6/ STAT3-mediated induction of suppressor of cytokine signal-3 (SOCS3).(10) Accordingly, hepatocyte-specific SOCS3 knockout (hKO SOCS3) mice show improved LR following hepatectomy.”
BackgroundCerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases
Casals, G., Perramón, M., Casals, E., Portolés, I., Fernández‐Varo, G., Morales‐Ruiz, M., Puntes, V., & Jiménez, W. (2021) · Antioxidants · doi:10.3390/antiox10050660 · Cited by 75 · see citing works
“After PHx, SOCS-3 is up-regulated, leading to the down-regulation of STAT-3, and, consequently, down-regulating IL-6 in a negative feedback manner [42,54].”
BackgroundHepatic regeneration in living donor liver transplantation
Olthoff, K. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50229 · Cited by 73 · see citing works
Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes #
Henkel, J., Neuschäfer‐Rube, F., Pathe‐Neuschäfer‐Rube, A., & Püschel, G. P. (2009) · Hepatology · doi:10.1002/hep.23064 · Cited by 73 · see citing works
IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: Regulation by SOCS3
Sun, R., Jaruga, B., Kulkarni, S., Sun, H., & Gao, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.171 · Cited by 72 · see citing works
Yin, S., Wang, H., Park, O., Wei, W., Shen, J., & Gao, B. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.01.001 · Cited by 69 · see citing works
Furchtgott, L., Chow, C. C., & Periwal, V. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.01.061 · Cited by 70 · see citing works
STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice†
Sun, R., Park, O., Horiguchi, N., Kulkarni, S., Jeong, W., Sun, H., Radaeva, S., & Gao, B. (2006) · Hepatology · doi:10.1002/hep.21344 · Cited by 68 · see citing works
do Amaral, M. E. C., Barbuio, R., Milanski, M., Romanatto, T., Barbosa, H. C. L., Nadruz, W., Bértolo, M. B., Boschero, A. C., Saad, M. J. A., Franchini, K. G., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03857.x · Cited by 66 · see citing works
Hepatocyte organoids and cell transplantation: What the future holds
Peng, W. C., Kraaier, L. J., & Kluiver, T. A. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00579-x · Cited by 59 · see citing works
Involvement of the innate immune system in liver regeneration and injury
Fausto, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.009 · Cited by 60 · see citing works
Self-citationQuétier, I., Brezillon, N., Duriez, M., Massinet, H., Giang, E., Ahodantin, J., Lamant, C., Brunelle-Navas, M.-N., Soussan, P., & Kremsdorf, D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.021 · Cited by 56 · see citing works
“We also observed an accumulation of SOCS3 transcript, a negative regulator of STAT3-dependent signalling and ERK1/2 activation [28].”
BackgroundLew, K. S., Pearson, J. T., Schwenke, D. O., & Katare, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0484-4 · Cited by 57 · see citing works
“Secondly, both TNF-α and IL-6 can stimulate suppressor of cytokinesignalling-1 and -3 proteins (SOCS-1, -3) expression [89, 90].”
BackgroundGrow, M. W., Neff, A. W., Mescher, A. L., et al. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20897 · Cited by 56 · see citing works
“Suppression of cytokine signaling by SOCS3 early in the postamputation regeneration-complete limb may be a critical event allowing for immune tolerance of dedifferentiating cells and regeneration to proceed.”
BackgroundInfluentialDe Jonge, J., Kurian, S., Shaked, A., Reddy, K. R., Hancock, W., Salomon, D. R., & Olthoff, K. M. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02557.x · Cited by 54 · see citing works
“There was a marked increase in genes of the IL-6/STAT3 pathway (24), including SOCS3, a feedback mediator that attenuates proinflammatory signaling and regulates STAT3 after partial hepatectomy (25), hepatocytes growth factor (HGF), a known stimulator of liver regeneration (3), and NFjB1, involved in regeneration and…”
BackgroundLiver Regeneration after Liver Transplantation
Taki‐Eldin, A., Zhou, L., Xie, H., & Zheng, S. (2012) · European Surgical Research · doi:10.1159/000337865 · Cited by 54 · see citing works
SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes
Gui, Y., Yeganeh, M., Ramanathan, S., LeBlanc, C., Pomerleau, V., Ferbeyre, G., Saucier, C., & Ilangumaran, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.027 · Cited by 52 · see citing works
“Transcription of Socs1 and Socs3 genes in the liver is induced by PH and following systemic administration of IL-6 [20,31,32].”
BackgroundLiver regeneration: a spotlight on the novel role of platelets and serotonin
Clavien, P. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12231 · Cited by 52 · see citing works
Graubardt, N., Fahrner, R., Trochsler, M., Keogh, A., Breu, K., Furer, C., Stroka, D., Robson, S. C., Slack, E. M. C., Candinas, D., et al. (2012) · Hepatology · doi:10.1002/hep.26008 · Cited by 51 · see citing works
Signalling links in the liver: Knitting SOCS with fat and inflammation
Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.004 · Cited by 51 · see citing works
Weng, H., Cai, X., Yuan, X., Liebe, R., Dooley, S., Li, H., & Wang, T. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00178 · Cited by 51 · see citing works
Role of liver progenitors in acute liver injury
Best, J., Dollé, L., Manka, P. P., Coombes, J. D., van Grunsven, L. A., & Syn, W. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00258 · Cited by 50 · see citing works
“Some of the putative factors that promote LPC expansion include cytokines IL6, TNFα, TGFβ, as well as cytokine regulated transcription factors nuclear factor kappa B, CCAAT enhancer binding protein beta, and growth factors HGF, EGF (Campbell et al., 2001).”
BackgroundRosiglitazone inhibits mouse liver regeneration
Turmelle, Y. P., Shikapwashya, O., Tu, S., Hruz, P. W., Yan, Q., & Rudnick, D. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6511fje · Cited by 49 · see citing works
“On the basis of these observations, the effects of rosiglitazone on expression of suppressor-of-cytokine-signaling (SOCS)-3 mRNA, which is a negative regulator of activated STAT3 induced during liver regeneration ( 37 ), was determined.”
Proliferation-inhibiting pathways in liver regeneration
Liu, M., & Chen, P. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6613 · Cited by 49 · see citing works
“The expression of SOCS3 is primarily induced by IL-6 and is also upregulated by other factors, including TNFα, IL-1, IL-22 and ZIP14, a zinc transporter (73,79-81).”
Shanmugam, N. K. N., Trebicka, E., Fu, L.-L., Shi, H. N., & Cherayil, B. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400278 · Cited by 49 · see citing works
Asai, K., Tamakawa, S., Yamamoto, M., Yoshie, M., Tokusashi, Y., Yaginuma, Y., Kasai, S., & Ogawa, K. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01267.x · Cited by 48 · see citing works
Erythropoietin promotes hepatic regeneration after extended liver resection in rats
Schmeding, M., Boas‐Knoop, S., Lippert, S., Ruehl, M., Somasundaram, R., Dagdelen, T., Neuhaus, P., & Neumann, U. P. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05265.x · Cited by 46 · see citing works
Vaquero, J., Campbell, J. S., Haque, J. A., McMahon, R. S., Riehle, K. J., Bauer, R. L., & Fausto, N. (2011) · Hepatology · doi:10.1002/hep.24420 · Cited by 45 · see citing works
“KO – – 52 (10-133) – 51 (40-59) 1 (0-10) 83 (73-85)”
Self-citationWang, H., Park, O., Lafdil, F., Shen, K., Horiguchi, N., Yin, S., Fu, X.-Y., Kunos, G., & Gao, B. (2009) · Hepatology · doi:10.1002/hep.23430 · Cited by 41 · see citing works
Role of liver progenitors in liver regeneration.
Best, J., Manka, P. P., Syn, W., Dollé, L., van Grunsven, L. A., & Canbay, A. E. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.16 · Cited by 41 · see citing works
“The majority of clinical trials conducted on MSCs for the treatment of liver diseases are based on three different sources of cells for transplantation: (I) unfractionated bone marrow, peripheral blood or cytokines (e.g., G-CSF) to mobilize cells; (II) immunoselected cell populations (CD34+ cells, CD133+ cells) from b…”
BackgroundYang, X., Schaper, F., Teubner, A., Lammert, F., Heinrich, P. C., Matern, S., & Siewert, E. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.048 · Cited by 41 · see citing works
Self-citationRole of NK, NKT cells and macrophages in liver transplantation
Fahrner, R., Dondorf, F., Ardelt, M., Settmacher, U., & Rauchfuß, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6135 · Cited by 41 · see citing works
Keller, R., Klein, M., Thomas, M., Dräger, A., Metzger, U., Templin, M. F., Joos, T. O., Thasler, W. E., Zell, A., & Zanger, U. M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004431 · Cited by 40 · see citing works
“This concentration had been previously shown in various cell models to activate STAT3 and to induce CRP expression without being toxic [41,42].”
BackgroundFathi-Kazerooni, M., Tavoosidana, G., Taghizadeh-Jahed, M., Khanjani, S., Golshahi, H., Gargett, C. E., Edalatkhah, H., & Kazemnejad, S. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.08.022 · Cited by 40 · see citing works
Liver regeneration--the best kept secret. A model of tissue injury response.
Cienfuegos, J. A., Rotellar, F., Baixauli, J., Martínez-Regueira, F., Pardo, F., & Hernández-Lizoáin, J. L. (2014) · PubMed · Cited by 40 · see citing works
Debonera, F., Krasinkas, A. M., Gelman, A. E., Aldeguer, X., Que, X., Shaked, A. A., & Olthoff, K. M. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.036 · Cited by 39 · see citing works
Sopasakis, V. R., Larsson, B.-M., Johansson, A., Holm�ng, A., & Smith, U. (2004) · Diabetologia · doi:10.1007/s00125-004-1544-y · Cited by 39 · see citing works
“Other target tissues for insulin action, such as the liver and skeletal muscle, also express the various components of the IL-6 signalling system [12, 13, 14, 15], supporting the possibility that whole-body insulin sensitivity may be modulated by IL-6.”
BackgroundHepatocyte growth control by SOCS1 and SOCS3
Khan, M. G. M., Ghosh, A., Variya, B. C., Santharam, M. A., Kandhi, R., Ramanathan, S., & Ilangumaran, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154733 · Cited by 37 · see citing works
A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration
Damrauer, S. M., Studer, P., da Silva, C. G., Longo, C. R., Ramsey, H. E., Csizmadia, E., Shrikhande, G., Scali, S. T., Libermann, T. A., Bhasin, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017715 · Cited by 37 · see citing works
Sass, G., Shembade, N., & Tiegs, G. (2005) · Biochemical Journal · doi:10.1042/bj20040279 · Cited by 37 · see citing works
Oroxylin A Accelerates Liver Regeneration in CCI4-Induced Acute Liver Injury Mice
Zhu, R., Zeng, G., Chen, Y., Zhang, Q., Liu, B., Liu, J., Chen, H., & Li, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071612 · Cited by 36 · see citing works
“Previous studies showed that liver regeneration and hepatoprotection require the cytokine IL-6 after liver injury [33,34], but overexpression of IL-6 causes liver injury [35,36].”
BackgroundMoreno-Carranza, B., Goya-Arce, M., Vega, C., Adán, N., Triebel, J., López-Barrera, F., Quintanar‐Stephano, A., Binart, N., de la Escalera, G. M., & Clapp, C. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00282.2013 · Cited by 36 · see citing works
“(11) and is upregulated by PRL in the liver (37), we examined”
BackgroundInfluentialGe, D., Gao, A. C., Zhang, Q., Liu, S., Xue, Y., & You, Z. (2011) · The Prostate · doi:10.1002/pros.22479 · Cited by 34 · see citing works
“Thus, the increased levels of CIS and SOCS7 expression desensitize LNCaP cells’ response to IL-6-induced NED.”
BackgroundInfluentialWhat is disrupting IFN-α's antiviral activity?
Mbow, M. L., & Sarisky, R. T. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.06.002 · Cited by 33 · see citing works
Qing, M., Nimmesgern, A., Heinrich, P. C., Schumacher, K., Vázquez-Jiménez, J. F., Hess, J., von Bernuth, G., & Seghaye, M.-C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000098858.64868.9c · Cited by 32 · see citing works
“In a model of partial hepatectomy, weak STAT-3 activation was observed in sham-operated mice (21).”
BackgroundSelf-citationLu, S., Shi, G., Xu, X., Wang, G., Xu, L., Sun, P. G., Li, X., Zhang, B., Gu, X., Ichim, T. E., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1051-1 · Cited by 31 · see citing works
“Increasing evidence has shown that IL-6 hyperstimulation is more likely to cause liver injury [45, 46].”
BackgroundLavon, I., Sheinin, T., Meilin, S., Biton, E., Weksler, A., Efroni, G., Bar-Joseph, A., Fink, G., & Avraham, A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1334 · Cited by 31 · see citing works
“Moreover, IL-6 injection induces SOCS-3 in the IL-6 KO animals, showing that IL-6 is required for SOCS-3 induction (Campbell et al., 2001).”
BackgroundZheng, X., Chen, X., Xu, L., Zhang, M., Feng, L., Yi, P., Tang, J., & Xu, M. (2017) · Cancer Science · doi:10.1111/cas.13167 · Cited by 29 · see citing works
Langdale, L. A., Hoagland, V. D., Benz, W., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.014 · Cited by 28 · see citing works
Self-citationTob1 is a constitutively expressed repressor of liver regeneration
Ho, K. J., Do, N. L., Otu, H. H., Dib, M. J., Ren, X., Enjyoji, K., Robson, S. C., Terwilliger, E. F., & Karp, S. J. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092434 · Cited by 27 · see citing works
“Our findings that both are increased after hepatectomy are consistent with published data (Sakamoto et al., 1999; Campbell et al., 2001).”
ResultZaazaa, A. M., Lokman, M. S., Shalby, A. B., et al. (2018) · PubMed · doi:10.22034/apjcp.2018.19.2.387 · Cited by 27 · see citing works
“IL-6 is a key player of the acute-phase response to inflammation, and by controlling the IL-6 – STAT3 pathway, SOCS3 acts as a controller of this response (Campbell et al., 2001).”
BackgroundPrognostic value of ZFP36 and SOCS3 expressions in human prostate cancer
Zhu, J., Yuan, D., Wenwen, C. H. E. N., Han, Z.-D., Liang, Y.-X., Chen, G., Fu, X., Liang, Y., Chen, G.-X., Sun, Z., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1432-6 · Cited by 26 · see citing works
“Some studies reported that ZFP36 and SOCS3 could inhibit the inflammation-induced cellular cancerization in vitro [29, 37] and defined as the inhibitors of tumor to regulate the cancerization [38].”
BackgroundKim, J. K., Lee, K. S., Chang, H. Y., Lee, W. K., & Lee, J. I. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-186 · Cited by 26 · see citing works
“Whole liver protein lysates were extracted using a TritonX 100 lysis buffer with protease inhibitors, and quantified using the Bradford method with BSA [34].”
MethodNitric Oxide in Liver Inflammation and Regeneration
Martín‐Sanz, P., Hortelano, S., Callejas, N. A., Goren, N., Casado, M., Zeini, M., & Boscá, L. (2002) · Metabolic Brain Disease · doi:10.1023/a:1021909902310 · Cited by 24 · see citing works
“…expression of genes that contribute to the maintenance of the hepatic-dependent homeostasis in the organism and that inhibit apoptosis and promote cell growth (Camargo et al., 1997; Campbell et al., 2001; Clavien, 1997; Cressman et al., 1996; Michalopoulos and DeFrances, 1997; Yamada et al., 1998).”
BackgroundSakuda, S., Tamura, S., Yamada, A., Miyagawa, J. I., Yamamoto, K., Kiso, S., Ito, N., Imanaka, K., Wada, A., Naka, T., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00282-3 · Cited by 25 · see citing works
The genetic regulation of the terminating phase of liver regeneration
Nygård, I. E., Mortensen, K. E., Hedegaard, J., Conley, L. N., Kalstad, T., Bendixen, C., & Revhaug, A. (2012) · Comparative Hepatology · doi:10.1186/1476-5926-11-3 · Cited by 24 · see citing works
“Amongst cytokines, several negative (Suppressors of Cytokine Signalling (SOCS), IL-6, Plasminogen Activating Inhibitor (PAI)) and positive regulators (Signal Transducer and Activator of Transcription proteins (STAT), Hepatocyte Growth Factor (HGF)) are reported to regulate cell growth [9-11].”
Background
- Authors
- Campbell, J. S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M. E., Argast, G. M., Heinrich, P. C., & Fausto, N.
- Affiliations
- University of Washington (US)
- RWTH Aachen University (DE)
- Corresponding author
- Fausto, Nelson
- Venue
- Journal of Clinical Investigation
- Published
- 2001-05-15
- Volume
- 107
- Issue
- 10
- Pages
- 1285-1292
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC209297
- OpenAlex
- W2013349369
- Cited by
- 156
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2019: 4 · 2018: 2 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 9 · 2012: 9
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (1r43ai023226-01, CA23226)
- National Cancer Institute (R01 CA074131, R37 CA023226, CA 74131, R01CA023226)
- National Institute of Allergy and Infectious Diseases (AI-23226)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32 DK09920-01, F32DK009920)
- National Institute of Environmental Health Sciences (T32-ES07032-23, T32ES007032)
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- suppressor of cytokine signaling, SOCS3, SOCS1, SOCS2, liver regeneration, partial hepatectomy, interleukin-6, TNF-α, STAT3 signaling, tyrosine phosphorylation, IL-6 knockout mice, TNF receptor 1
- MeSH terms
- Suppressor of Cytokine Signaling 3 Protein, Animals, DNA-Binding Proteins, Gene Expression Regulation, Hepatectomy, Liver Regeneration, Proteins, Repressor Proteins, Transcription Factors, Tumor Necrosis Factor-alpha, Signal Transduction, Trans-Activators, Antigens, CD, Interleukin-6, Receptors, Tumor Necrosis Factor, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, STAT3 Transcription Factor, Suppressor of Cytokine Signaling Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review